Anika Therapeutics, Inc. (ANIK)
USD 14.13
(-3.81%)
USD 14.13
(-3.81%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 26.9 Million USD | -6.64% |
| 2022 | 28.81 Million USD | 49.78% |
| 2021 | 19.24 Million USD | -7.85% |
| 2020 | 20.87 Million USD | -2.28% |
| 2019 | 21.36 Million USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | -100.0% |
| 2012 | 8 Million USD | -16.67% |
| 2011 | 9.6 Million USD | -14.29% |
| 2010 | 11.2 Million USD | -12.5% |
| 2009 | 12.8 Million USD | -99.91% |
| 2008 | 14.4 Billion USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| 1995 | - USD | -100.0% |
| 1994 | 1 Million USD | 0.0% |
| 1993 | 1 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 25.78 Million USD | 0.0% |
| 2024 Q1 | 26.34 Million USD | 0.0% |
| 2024 Q3 | 25.24 Million USD | 0.0% |
| 2023 Q2 | 27.77 Million USD | -1.79% |
| 2023 Q1 | 28.28 Million USD | -1.86% |
| 2023 FY | 26.9 Million USD | -6.64% |
| 2023 Q4 | 26.9 Million USD | -1.28% |
| 2023 Q3 | 27.25 Million USD | -1.88% |
| 2022 FY | 28.81 Million USD | 49.78% |
| 2022 Q4 | 28.81 Million USD | -1.25% |
| 2022 Q2 | 29.73 Million USD | 57.98% |
| 2022 Q1 | 18.82 Million USD | -2.18% |
| 2022 Q3 | 29.18 Million USD | -1.85% |
| 2021 Q4 | 19.24 Million USD | -2.03% |
| 2021 FY | 19.24 Million USD | -7.85% |
| 2021 Q1 | 20.54 Million USD | -1.61% |
| 2021 Q2 | 20.08 Million USD | -2.25% |
| 2021 Q3 | 19.63 Million USD | -2.2% |
| 2020 Q1 | 21.73 Million USD | 1.7% |
| 2020 Q2 | 71.41 Million USD | 228.63% |
| 2020 Q3 | 46.13 Million USD | -35.4% |
| 2020 Q4 | 20.87 Million USD | -54.74% |
| 2020 FY | 20.87 Million USD | -2.28% |
| 2019 Q2 | 21.97 Million USD | -1.16% |
| 2019 Q1 | 22.23 Million USD | 0.0% |
| 2019 Q4 | 21.36 Million USD | -1.09% |
| 2019 Q3 | 21.6 Million USD | -1.69% |
| 2019 FY | 21.36 Million USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2013 Q1 | 7.6 Million USD | -5.0% |
| 2013 Q4 | - USD | -100.0% |
| 2013 Q3 | 6.8 Million USD | -5.56% |
| 2013 Q2 | 7.2 Million USD | -5.26% |
| 2013 FY | - USD | -100.0% |
| 2012 FY | 8 Million USD | -16.67% |
| 2012 Q2 | 8.8 Million USD | -4.35% |
| 2012 Q4 | 8 Million USD | -4.76% |
| 2012 Q3 | 8.4 Million USD | -4.55% |
| 2012 Q1 | 9.2 Million USD | -4.17% |
| 2011 FY | 9.6 Million USD | -14.29% |
| 2011 Q4 | 9.6 Million USD | -4.0% |
| 2011 Q3 | 10 Million USD | -3.85% |
| 2011 Q2 | 10.4 Million USD | -3.7% |
| 2011 Q1 | 10.8 Million USD | -3.57% |
| 2010 FY | 11.2 Million USD | -12.5% |
| 2010 Q2 | 12 Million USD | -3.23% |
| 2010 Q3 | 11.6 Million USD | -3.33% |
| 2010 Q1 | 12.4 Million USD | -3.13% |
| 2010 Q4 | 11.2 Million USD | -3.45% |
| 2009 Q3 | 13.2 Million USD | -2.94% |
| 2009 FY | 12.8 Million USD | -99.91% |
| 2009 Q2 | 13.6 Million USD | -2.86% |
| 2009 Q1 | 14 Million USD | -99.9% |
| 2009 Q4 | 12.8 Million USD | -3.03% |
| 2008 Q3 | 7.4 Million USD | -2.63% |
| 2008 Q4 | 14.4 Billion USD | 194494.59% |
| 2008 FY | 14.4 Billion USD | 0.0% |
| 2008 Q1 | 3.9 Million USD | 0.0% |
| 2008 Q2 | 7.6 Million USD | 94.87% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q3 | 29.18 Million USD | 0.0% |
| 2001 Q4 | - USD | -100.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q1 | 100 Thousand USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q2 | - USD | -100.0% |
| 1997 Q4 | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1995 Q3 | - USD | 0.0% |
| 1995 Q4 | - USD | 0.0% |
| 1995 Q1 | 1 Million USD | 0.0% |
| 1995 Q2 | - USD | -100.0% |
| 1995 FY | - USD | -100.0% |
| 1994 FY | 1 Million USD | 0.0% |
| 1994 Q1 | 1 Million USD | 0.0% |
| 1994 Q3 | 1 Million USD | 0.0% |
| 1994 Q4 | 1 Million USD | 0.0% |
| 1994 Q2 | 1 Million USD | 0.0% |
| 1993 FY | 1 Million USD | 0.0% |
| 1993 Q3 | 1 Million USD | 11.11% |
| 1993 Q2 | 900 Thousand USD | 0.0% |
| 1993 Q4 | 1 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | 25.478% |
| BrainsWay Ltd. | 239 Thousand USD | -11156.904% |
| Cerus Corporation | 59.79 Million USD | 55.007% |
| Envoy Medical, Inc. | 404 Thousand USD | -6559.406% |
| electroCore, Inc. | 537 Thousand USD | -4910.056% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -224100.0% |
| IceCure Medical Ltd | 376 Thousand USD | -7055.319% |
| Inogen, Inc. | 18.27 Million USD | -47.258% |
| OrthoPediatrics Corp. | 13.45 Million USD | -99.896% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -13419.598% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -7296.817% |
| MaxCyte, Inc. | 17.96 Million USD | -49.725% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -48565.075% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| Orthofix Medical Inc. | 93.1 Million USD | 71.104% |
| PAVmed Inc | 2.96 Million USD | -808.919% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | -332.958% |
| RxSight, Inc. | 1.21 Million USD | -2121.635% |
| Sight Sciences, Inc. | 31.7 Million USD | 15.151% |
| SI-BONE, Inc. | 36.06 Million USD | 25.401% |
| TELA Bio, Inc. | 40.51 Million USD | 33.595% |
| Treace Medical Concepts, Inc. | 53 Million USD | 49.245% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | -1668.836% |
| Acutus Medical, Inc. | 32.65 Million USD | 17.609% |
| Talis Biomedical Corporation | 16.78 Million USD | -60.276% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | -565.117% |
| CVRx, Inc. | 30.38 Million USD | 11.448% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 1.01 Million USD | -2545.61% |
| Bioventus Inc. | 366.99 Million USD | 92.669% |
| Venus Concept Inc. | 70.79 Million USD | 61.995% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | -2062.701% |
| LivaNova PLC | 568.54 Million USD | 95.268% |
| 908 Devices Inc. | 3.92 Million USD | -584.754% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 94.735% |
| Nemaura Medical Inc. | 3.08 Million USD | -771.342% |
| NeuroPace, Inc. | 56.95 Million USD | 52.762% |
| LENSAR, Inc. | 1.75 Million USD | -1437.371% |
| Apyx Medical Corporation | 33.18 Million USD | 18.927% |
| Cutera, Inc. | 418.69 Million USD | 93.574% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | -78.835% |
| BioSig Technologies, Inc. | 103 Thousand USD | -26020.388% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | -170.419% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 98.188% |
| Axonics, Inc. | 25.84 Million USD | -4.118% |
| Outset Medical, Inc. | 134.59 Million USD | 80.011% |
| IRIDEX Corporation | 1.75 Million USD | -1436.493% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | 47.595% |
| IRadimed Corporation | 1.61 Million USD | -1565.8% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -15186.364% |
| INVO Bioscience, Inc. | 6.77 Million USD | -297.043% |
| Telesis Bio, Inc. | 5.26 Million USD | -410.609% |
| Viemed Healthcare, Inc. | 5.97 Million USD | -350.556% |
| Varex Imaging Corporation | 464.2 Million USD | 94.204% |
| Quipt Home Medical Corp. | 60.82 Million USD | 55.765% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -4475.51% |
| Pulmonx Corporation | 35.08 Million USD | 23.326% |
| Dynatronics Corporation | 3.25 Million USD | -725.662% |
| Modular Medical, Inc. | 817 Thousand USD | -3193.023% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -17717.219% |
| Semler Scientific, Inc. | 70 Thousand USD | -38334.286% |
| InMode Ltd. | 6.61 Million USD | -306.835% |
| Bruker Corporation | 1.14 Billion USD | 97.649% |
| Cytosorbents Corporation | 2.54 Million USD | -958.023% |
| DexCom, Inc. | 2.57 Billion USD | 98.954% |
| Align Technology, Inc. | 96.96 Million USD | 72.255% |
| Viveve Medical, Inc. | 5.12 Million USD | -425.059% |
| ZimVie Inc. | 508.79 Million USD | 94.712% |
| Movano Inc. | 15.00 USD | -179359900.0% |
| Cytek Biosciences, Inc. | 18.12 Million USD | -48.436% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 93.25% |
| Profound Medical Corp. | 4.97 Million USD | -440.847% |
| Insulet Corporation | 1.36 Billion USD | 98.031% |
| enVVeno Medical Corporation | 1.06 Million USD | -2428.571% |
| Surmodics, Inc. | 29.4 Million USD | 8.505% |
| iCAD, Inc. | 273 Thousand USD | -9754.945% |
| Nuwellis, Inc. | 221 Thousand USD | -12073.756% |
| Biotricity, Inc. | 10.85 Million USD | -147.83% |
| iRhythm Technologies, Inc. | 34.95 Million USD | 23.021% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | -4040.663% |
| InspireMD, Inc. | 1.03 Million USD | -2491.908% |
| PAVmed Inc. | 2.96 Million USD | -808.919% |
| BIOLASE, Inc. | 13.98 Million USD | -92.378% |
| Beyond Air, Inc. | 14.72 Million USD | -82.759% |
| FONAR Corporation | 37.92 Million USD | 29.068% |
| AxoGen, Inc. | 46.6 Million USD | 42.27% |
| Vivani Medical, Inc. | 19.31 Million USD | -39.305% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | 39.693% |
| Inari Medical, Inc. | 30.35 Million USD | 11.369% |
| UFP Technologies, Inc. | 28 Million USD | 3.914% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | -6098.436% |
| Tenon Medical, Inc. | 428 Thousand USD | -6185.981% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -2585.03% |
| Co-Diagnostics, Inc. | 2.15 Million USD | -1150.081% |
| AdaptHealth Corp. | 2.09 Billion USD | 98.716% |
| Sintx Technologies, Inc. | 3.68 Million USD | -629.699% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | 27.722% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -4475.51% |
| Sensus Healthcare, Inc. | 596 Thousand USD | -4414.094% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 96.985% |
| TransMedics Group, Inc. | 506.2 Million USD | 94.685% |
| ReWalk Robotics Ltd. | 607 Thousand USD | -4332.29% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -28990.123% |
| Hyperfine, Inc. | 64 Thousand USD | -41937.5% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 85.745% |
| Biomerica, Inc. | 459 Thousand USD | -5761.438% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -5885.543% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -14060.969% |
| Silk Road Medical, Inc | 75.62 Million USD | 64.425% |